Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Revenue PerformanceStable
Percentile Rank50
3Y CAGR-0.3%
5Y CAGR-2.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-0.3%/yr
vs +1.9%/yr prior
5Y CAGR
-2.9%/yr
Consistent
Acceleration
-2.2pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
2025$112.82M-5.9%
2024$119.91M-0.7%
2023$120.79M+6.1%
2022$113.83M-23.0%
2021$147.79M+13.3%
2020$130.46M+13.8%
2019$114.61M+8.6%
2018$105.56M-6.9%
2017$113.42M+9.7%
2016$103.38M-